The antihypertensive and vasodilator effects of aqueous extract from Berberis vulgaris fruit on hypertensive ratsFATEHI-HASSANABAD, Zahra; JAFARZADEH, Mostafa; TARHINI, Ahmad et al.PTR. Phytotherapy research. 2005, Vol 19, Num 3, pp 222-225, issn 0951-418X, 4 p.Article

Prognostic Significance of Serum S100B Protein in High-Risk Surgically Resected Melanoma Patients Participating in Intergroup Trial ECOG 1694TARHINI, Ahmad A; STUCKERT, Joseph; LEE, Sandra et al.Journal of clinical oncology. 2009, Vol 27, Num 1, pp 38-44, issn 0732-183X, 7 p.Article

Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapyTARHINI, Ahmad A; KIRKWOOD, John M; GOADING, William E et al.Journal of clinical oncology. 2007, Vol 25, Num 25, pp 3802-3807, issn 0732-183X, 6 p.Article

Prognostic significance of autoimmunity during treatment of melanoma with interferonKRAUZE, Michal T; TARHINI, Ahmad; GOGAS, Helen et al.Seminars in immunopathology (Print). 2011, Vol 33, Num 4, pp 385-391, issn 1863-2297, 7 p.Article

A Phase 2 Trial of Sequential Temozolomide Chemotherapy Followed by High-Dose Interleukin 2 Immunotherapy for Metastatic MelanomaTARHINI, Ahmad A; KIRKWOOD, John M; GOODING, William E et al.Cancer. 2008, Vol 113, Num 7, pp 1632-1640, issn 0008-543X, 9 p.Article

Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic LeukemiaFOON, Kenneth A; BOYIADZIS, Michael; SCHAEFER, Patricia et al.Journal of clinical oncology. 2009, Vol 27, Num 4, pp 498-503, issn 0732-183X, 6 p.Article

Practical Guidelines for the Management of Interferon-α-2b Side Effects in Patients Receiving Adjuvant Treatment for Melanoma : Expert OpinionHAUSCHILD, Axel; GOGAS, Helen; TARHINI, Ahmad et al.Cancer. 2008, Vol 112, Num 5, pp 982-994, issn 0008-543X, 13 p.Article

Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumorsKIRKWOOD, John M; TARHINI, Ahmad; SPARANO, Joseph A et al.Cancer treatment reviews. 2013, Vol 39, Num 1, pp 27-43, issn 0305-7372, 17 p.Article

Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapyKIRKWOOD, John M; BENDER, Catherine; AGARWALA, Sanjiv et al.Journal of clinical oncology. 2002, Vol 20, Num 17, pp 3703-3718, issn 0732-183XArticle

Outcome predictors of Gamma Knife surgery for melanoma brain metastases: Clinical articleLIEW, Donald N; KANO, Hideyuki; KONDZIOLKA, Douglas et al.Journal of neurosurgery. 2011, Vol 114, Num 3, pp 769-779, issn 0022-3085, 11 p.Article

Phase II Study of Everolimus (RAD001) in Previously Treated Small Cell Lung CancerTARHINI, Ahmad; KOTSAKIS, Athanasios; GOODING, William et al.Clinical cancer research (Print). 2010, Vol 16, Num 23, pp 5900-5907, issn 1078-0432, 8 p.Article

Safety and Efficacy of Arsenic Trioxide for Patients With Advanced Metastatic MelanomaTARHINI, Ahmad A; KIRKWOOD, John M; TAWBI, Hussein et al.Cancer. 2008, Vol 112, Num 5, pp 1131-1138, issn 0008-543X, 8 p.Article

Safety and Immunogenicity of Vaccination With MART-1 (26-35, 27L), gp100 (209-217, 210M), and Tyrosinase (368-376, 370D) In Adjuvant With PF-3512676 and GM-CSF In Metastatic MelanomaTARHINI, Ahmad A; SIYANG LENG; MOSCHOS, Stergios J et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 4, pp 359-366, issn 1524-9557, 8 p.Article

Differing Patterns of Circulating Regulatory T Cells and Myeloid-derived Suppressor Cells in Metastatic Melanoma Patients Receiving Anti-CTLA4 Antibody and Interferon-α or TLR-9 Agonist and GM-CSF With Peptide VaccinationTARHINI, Ahmad A; BUTTERFIELD, Lisa H; SHUAI, Yongli et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 9, pp 702-710, issn 1524-9557, 9 p.Article

ECOG Phase II Trial of Graded-Dose Peginterferon α-2b in Patients with Metastatic Melanoma Overexpressing Basic Fibroblast Growth Factor (E2602)GO, Ronald S; LEE, Sandra J; DONGHOON SHIN et al.Clinical cancer research (Print). 2013, Vol 19, Num 23, pp 6597-6604, issn 1078-0432, 8 p.Article

A Phase 2, Randomized Study of SB-485232, rhIL-18, in Patients With Previously Untreated Metastatic MelanomaTARHINI, Ahmad A; MILLWARD, Michael; MAINWARING, Paul et al.Cancer. 2009, Vol 115, Num 4, pp 859-868, issn 0008-543X, 10 p.Article

Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV MelanomaTARHINI, Ahmad A; CHERIAN, John; MOSCHOS, Stergios J et al.Journal of clinical oncology. 2012, Vol 30, Num 3, pp 322-328, issn 0732-183X, 7 p.Article

Next Generation of Immunotherapy for MelanomaKIRKWOOD, John M; TARHINI, Ahmad A; PANELLI, Monica C et al.Journal of clinical oncology. 2008, Vol 26, Num 20, pp 3445-3455, issn 0732-183X, 11 p.Article

Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma: A Randomized Clinical TrialHODI, F. Stephen; LEE, Sandra; McDERMOTT, David F et al.JAMA, the journal of the American Medical Association. 2014, Vol 312, Num 17, pp 1744-1753, issn 0098-7484, 10 p.Article

Aflibercept (VEGF Trap) in Inoperable Stage III or Stage IV Melanoma of Cutaneous or Uveal OriginTARHINI, Ahmad A; FRANKEL, Paul; MARGOLIN, Kim A et al.Clinical cancer research (Print). 2011, Vol 17, Num 20, pp 6574-6581, issn 1078-0432, 8 p.Article

A Phase I Study of Concurrent Chemotherapy (Paclitaxel and Carboplatin) and Thoracic Radiotherapy with Swallowed Manganese Superoxide Dismutase Plasmid Liposome Protection in Patients with Locally Advanced Stage III Non-Small-Cell Lung CancerTARHINI, Ahmad A; BELANI, Chandra P; CHAMPIONSMITH, Tony et al.Human gene therapy. 2011, Vol 22, Num 3, pp 336-342, issn 1043-0342, 7 p.Article

PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8⁺ T Cells Induced by Melanoma VaccinesFOURCADE, Julien; ZHAOJUN SUN; HONG WANG et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 4, pp 1045-1055, issn 0008-5472, 11 p.Article